U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of Finance, Budget, Acquisitions, and Planning
  6. Office of Finance, Budget, Acquisitions, and Planning - Office of Planning, Evaluation, and Risk Management
  1. Office of Finance, Budget, Acquisitions, and Planning

Office of Planning, Evaluation, and Risk Management

Vision

Delivering world-class public service that drives meaningful improvements to public health outcomes with greater productivity and transparency.

Mission

OPERM partners with FDA leaders to achieve organizational excellence by improving agency-wide planning, program performance, governance, operational efficiency, and enterprise risk management. 

Major Functions

The Office of Planning, Evaluation and Enterprise Risk Management, in partnership with FDA senior management, leads the Agency through the full portfolio of planning, performance management, evaluation, and risk management activities called for by FDA and Administration leadership and Federal law. 

Our functions include strategic and related planning, program management, change and risk management, evaluation studies, activities in support of budget formulation, coordination of internal controls and compliance, and associated research, analysis, optimization, and best practices activities in the development and implementation of public health outcome measures related to FDA's mission.

The Office’s work assists FDA officials, the Department of Health and Human Services, and members of Congress make well-informed decisions related to planning and managing programs, policies, processes, budgets, and risks and opportunities to advance FDA’s mission and priorities. We also often serve as FDA liaison to Department and Administration planning activities that affect multiple FDA components.

Our key responsibilities include the following:

  • Design and facilitate development of strategic and related plans and performance management systems.
  • Analyze management performance trends, Agency cost structure, and use of program resources.
  • Oversee certain user fee performance commitments and performance management resources.
  • Provide leadership, guidance, and partnering on the overall management of FDA’s enterprise and next-level risks. 
  • Provide framework for effective internal controls and compliance.
  • Manage the full lifecycle of FDA reorganizations and delegation of authority proposals
  • Provide assistance to Agency components in change management, program  reinvention, managing-to-cost, and business process improvements.

Contact the Office of Planning, Evaluation, and Risk Management

Yashika Rahaman, Ph.D., Director

Phone: 301-796-3843 

E-mail: Yashika.Rahaman@fda.hhs.gov



Back to Top